{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:09:33Z","timestamp":1794852573104,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373813"],"award-info":[{"award-number":["82373813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22273023"],"award-info":[{"award-number":["22273023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101131"],"award-info":[{"award-number":["32101131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077034"],"award-info":[{"award-number":["22077034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55721-w","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:49:51Z","timestamp":1735879791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Ionizable polymeric micelles (IPMs) for efficient siRNA delivery"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6587-3056","authenticated-orcid":false,"given":"Ziyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-2829","authenticated-orcid":false,"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4199-8175","authenticated-orcid":false,"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7036-1517","authenticated-orcid":false,"given":"Kuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-5757","authenticated-orcid":false,"given":"Zhiqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"55721_CR1","doi-asserted-by":"crossref","unstructured":"Pattipeiluhu, R. et al. Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection. Nat. Commun. 15, 1303 (2024).","DOI":"10.1038\/s41467-024-45666-5"},{"key":"55721_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s12276-022-00757-5","volume":"54","author":"Y-K Kim","year":"2022","unstructured":"Kim, Y.-K. RNA therapy: rich history, various applications and unlimited future prospects. Exp. Mol. Med. 54, 455\u2013465 (2022).","journal-title":"Exp. Mol. Med."},{"key":"55721_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"55721_CR4","doi-asserted-by":"crossref","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","DOI":"10.1056\/NEJMoa2034577"},{"key":"55721_CR5","doi-asserted-by":"crossref","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","DOI":"10.1056\/NEJMoa2035389"},{"key":"55721_CR6","doi-asserted-by":"crossref","unstructured":"Liu, K. et al. Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function. Nat. Commun. 14, 4007 (2023).","DOI":"10.1038\/s41467-023-39768-9"},{"key":"55721_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","volume":"7","author":"LH Rhym","year":"2023","unstructured":"Rhym, L. H., Manan, R. S., Koller, A., Stephanie, G. & Anderson, D. G. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery. Nat. Biomed. Eng. 7, 901\u2013910 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"55721_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","volume":"8","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity. Nat. Biomed. Eng. 8, 544\u2013560 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"55721_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00766-z","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats. NPJ Vaccines 8, 169 (2023).","journal-title":"NPJ Vaccines"},{"key":"55721_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"55721_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41551-022-00847-9","volume":"6","author":"CD Sago","year":"2022","unstructured":"Sago, C. D. et al. Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver. Nat. Biomed. Eng. 6, 157\u2013167 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"55721_CR12","doi-asserted-by":"crossref","unstructured":"Lokugamage, M. P. et al. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nat. Biomed. Eng. 5, 1059\u20131068 (2021).","DOI":"10.1038\/s41551-021-00786-x"},{"key":"55721_CR13","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"55721_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45422-9","volume":"15","author":"L Xue","year":"2024","unstructured":"Xue, L. et al. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models. Nat. Commun. 15, 1884 (2024).","journal-title":"Nat. Commun."},{"key":"55721_CR15","doi-asserted-by":"crossref","unstructured":"Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).","DOI":"10.1073\/pnas.2116271119"},{"key":"55721_CR16","doi-asserted-by":"crossref","unstructured":"Zhao, G. et al. TGF-\u03b2R2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue. Sci. Transl. Med. 16, eadg6229 (2024).","DOI":"10.1126\/scitranslmed.adg6229"},{"key":"55721_CR17","doi-asserted-by":"publisher","first-page":"eabb4429","DOI":"10.1126\/sciadv.abb4429","volume":"6","author":"F Ma","year":"2020","unstructured":"Ma, F. et al. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci. Adv. 6, eabb4429 (2020).","journal-title":"Sci. Adv."},{"key":"55721_CR18","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1021\/jacs.2c02706","volume":"144","author":"L Xue","year":"2022","unstructured":"Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 9926\u20139937 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"55721_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01680-8","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-024-01680-8 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"55721_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41565-018-0358-x","volume":"14","author":"S Guan","year":"2019","unstructured":"Guan, S. et al. Self-assembled peptide\u2013poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis. Nat. Nanotechnol. 14, 287\u2013297 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"55721_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55721_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","volume":"22","author":"R Zhong","year":"2023","unstructured":"Zhong, R. et al. Hydrogels for RNA delivery. Nat .Mater 22, 818\u2013831 (2023).","journal-title":"Nat .Mater"},{"key":"55721_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.annonc.2020.10.479","volume":"32","author":"M Shi","year":"2021","unstructured":"Shi, M. et al. Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial. Ann. Oncol. 32, 85\u201396 (2021).","journal-title":"Ann. Oncol."},{"key":"55721_CR24","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","volume":"18","author":"D-W Kim","year":"2007","unstructured":"Kim, D.-W. et al. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009\u20132014 (2007).","journal-title":"Ann. Oncol."},{"key":"55721_CR25","doi-asserted-by":"crossref","unstructured":"Liu, N., Bechinger, B. & S\u00fcss, R. The histidine-rich peptide LAH4-L1 strongly promotes PAMAM-mediated transfection at low nitrogen to phosphorus ratios in the presence of serum. Sci. Rep. 7, 9585 (2017).","DOI":"10.1038\/s41598-017-10049-y"},{"key":"55721_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","volume":"362","author":"J Casper","year":"2023","unstructured":"Casper, J. et al. Polyethylenimine (PEI) in gene therapy: current status and clinical applications. J. Controlled Release 362, 667\u2013691 (2023).","journal-title":"J. Controlled Release"},{"key":"55721_CR27","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1039\/C9BM01025D","volume":"7","author":"G Zhao","year":"2019","unstructured":"Zhao, G. et al. Nanoparticle-delivered siRNA targeting Bruton\u2019s tyrosine kinase for rheumatoid arthritis therapy. Biomater. Sci. 7, 4698\u20134707 (2019).","journal-title":"Biomater. Sci."},{"key":"55721_CR28","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Dually regulating the proliferation and the immune microenvironment of melanoma: Via nanoparticle-delivered siRNA targeting onco-immunologic CD155. Biomater. Sci. 8, 6683\u20136694 (2020).","DOI":"10.1039\/D0BM01420F"},{"key":"55721_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265\u2013280 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"55721_CR30","unstructured":"Li, X., Wang, S. & Li, Z. Updated key points of Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis (2018). J. Clin. Hepatol. 35, 1485\u20131488 (2019)."},{"key":"55721_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li, X. et al. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat. Rev. Cancer 21, 541\u2013557 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"55721_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42058-z","volume":"14","author":"Y Tsuchiya","year":"2023","unstructured":"Tsuchiya, Y. et al. Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat. Commun. 14, 6304 (2023).","journal-title":"Nat. Commun."},{"key":"55721_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40328-4","volume":"14","author":"J Boursier","year":"2023","unstructured":"Boursier, J. et al. Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests. Nat. Commun. 14, 5219 (2023).","journal-title":"Nat. Commun."},{"key":"55721_CR34","doi-asserted-by":"crossref","unstructured":"Wan, S. et al. Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition. Cell Death Dis. 15, 41 (2024).","DOI":"10.1038\/s41419-024-06437-8"},{"key":"55721_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06509-9","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis. Cell Death Dis. 15, 189 (2024).","journal-title":"Cell Death Dis."},{"key":"55721_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53599-8","volume":"14","author":"F Mao","year":"2024","unstructured":"Mao, F. et al. Identification of pyroptosis-related gene signature in nonalcoholic steatohepatitis. Sci. Rep. 14, 3175 (2024).","journal-title":"Sci. Rep."},{"key":"55721_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri3062","volume":"11","author":"KY King","year":"2011","unstructured":"King, K. Y. & Goodell, M. A. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685\u2013692 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"55721_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","volume":"9","author":"J-L Lu","year":"2023","unstructured":"Lu, J.-L., Yu, C.-X. & Song, L.-J. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discov. 9, 449 (2023).","journal-title":"Cell Death Discov."},{"key":"55721_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","volume":"20","author":"LA D\u00edaz","year":"2023","unstructured":"D\u00edaz, L. A., Arab, J. P., Louvet, A., Bataller, R. & Arrese, M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 20, 764\u2013783 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"55721_CR40","doi-asserted-by":"crossref","unstructured":"Li, J. et al. HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis. Clin. Sci. 132, 1645\u20131667 (2018).","DOI":"10.1042\/CS20180177"},{"key":"55721_CR41","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke, F. Targeting hepatic macrophages to treat liver diseases. J. Hepatol. 66, 1300\u20131312 (2017).","journal-title":"J. Hepatol."},{"key":"55721_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrgastro.2016.58","volume":"13","author":"LA Borthwick","year":"2016","unstructured":"Borthwick, L. A. & Mann, D. A. Osteopontin and HMGB1: novel regulators of HSC activation. Nat. Rev. Gastroenterol. Hepatol. 13, 320\u2013322 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"55721_CR43","doi-asserted-by":"crossref","unstructured":"Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26, 431\u2013442 (2008).","DOI":"10.1038\/nbt1396"},{"key":"55721_CR44","doi-asserted-by":"crossref","unstructured":"Han, X. et al. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat. Commun. 14, 75 (2023).","DOI":"10.1038\/s41467-022-35637-z"},{"key":"55721_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","volume":"343","author":"JE Zhou","year":"2022","unstructured":"Zhou, J. E. et al. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J. Controlled Release 343, 175\u2013186 (2022).","journal-title":"J. Controlled Release"},{"key":"55721_CR46","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","volume":"14","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Liver-Targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities. ACS Nano 14, 6305\u20136322 (2020).","journal-title":"ACS Nano"},{"key":"55721_CR47","doi-asserted-by":"crossref","unstructured":"Buschmann, M. D. et al. Nanomaterial Delivery Systems for mRNA Vaccines. Vaccines 9, 65 (2021)","DOI":"10.3390\/vaccines9010065"},{"key":"55721_CR48","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172\u2013176 (2010)."},{"key":"55721_CR49","doi-asserted-by":"crossref","unstructured":"Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, 1805097 (2019).","DOI":"10.1002\/smll.201805097"},{"key":"55721_CR50","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1021\/acs.nanolett.0c04806","volume":"21","author":"Y Chu","year":"2021","unstructured":"Chu, Y. et al. Deciphering protein corona by scFv-based affinity chromatography. Nano Lett. 21, 2124\u20132131 (2021).","journal-title":"Nano Lett."},{"key":"55721_CR51","doi-asserted-by":"crossref","unstructured":"Allison, S. J. & Milner, J. RNA interference by single- and double-stranded siRNA with a DNA extension containing a 3\u2032 nuclease-resistant mini-hairpin structure. Mol. Ther. Nucleic Acids 3, 141 (2014).","DOI":"10.1038\/mtna.2013.68"},{"key":"55721_CR52","doi-asserted-by":"crossref","unstructured":"Kumar, V. et al. Shielding of lipid nanoparticles for siRNA delivery: Impact on physicochemical properties, cytokine induction, and efficacy. Mol. Ther. Nucleic Acids 3, 210 (2014).","DOI":"10.1038\/mtna.2014.61"},{"key":"55721_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16248-y","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao, L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat. Commun. 11, 2424 (2020).","journal-title":"Nat. Commun."},{"key":"55721_CR54","doi-asserted-by":"crossref","unstructured":"Sato, Y., Kinami, Y., Hashiba, K. & Harashima, H. Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E\/low density lipoprotein receptor and the N-acetyl-D-galactosamine\/asialoglycoprotein receptor pathway. J. Controlled Release 322, 217\u2013226 (2020).","DOI":"10.1016\/j.jconrel.2020.03.006"},{"key":"55721_CR55","doi-asserted-by":"crossref","unstructured":"Pattipeiluhu, R. et al. Anionic lipid nanoparticles preferentially deliver mRNA to the hepatic reticuloendothelial system. Adv. Mater. 34,2201095 (2022).","DOI":"10.1002\/adma.202201095"},{"key":"55721_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes, B. B. et al. Nanodelivery of nucleic acids. Nat. Rev. Methods Prim. 2, 24 (2022).","journal-title":"Nat. Rev. Methods Prim."},{"key":"55721_CR57","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee, Y., Jeong, M., Park, J., Jung, H. & Lee, H. Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp. Mol. Med. 55, 2085\u20132096 (2023).","journal-title":"Exp. Mol. Med."},{"key":"55721_CR58","doi-asserted-by":"crossref","unstructured":"Pan, J. et al. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy. Adv. Mater. 35, 2301779 (2023).","DOI":"10.1002\/adma.202301779"},{"key":"55721_CR59","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41565-023-01374-7","volume":"18","author":"Z Luo","year":"2023","unstructured":"Luo, Z. et al. Neutrophil hitchhiking for drug delivery to the bone marrow. Nat. Nanotechnol. 18, 647\u2013656 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"55721_CR60","doi-asserted-by":"crossref","unstructured":"Li, M. et al. Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy. Nat. Commun. 11, 1126 (2020).","DOI":"10.1038\/s41467-020-14963-0"},{"key":"55721_CR61","doi-asserted-by":"crossref","unstructured":"Frisch, M. J. et al. Gaussian 16 Rev. C.01. (2016).","DOI":"10.5965\/1984723816322015001"},{"key":"55721_CR62","doi-asserted-by":"crossref","unstructured":"Chai, J. Da & Head-Gordon, M. Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys. Chem. Chem. Phys. 10, 6615\u20136620 (2008).","DOI":"10.1039\/b810189b"},{"key":"55721_CR63","doi-asserted-by":"crossref","unstructured":"Liptak, M. D. & Shields, G. C. Accurate pKa calculations for carboxylic acids using Complete Basis Set and Gaussian-n models combined with CPCM continuum solvation methods. J. Am. Chem. Soc. 123, 7314\u20137319 (2001).","DOI":"10.1021\/ja010534f"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55721-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55721-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55721-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:05:30Z","timestamp":1735880730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55721-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55721"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55721-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}